Skip to content

Acupuncture treatment of sensorineural hearing loss with MCI clinical efficacy and related mechanisms

Acupuncture treatment of sensorineural hearing loss with MCI clinical efficacy and related mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100005203
Enrollment
Unknown
Registered
2021-08-26
Start date
2021-08-27
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sensorineural hearing loss

Interventions

Test Group:Acupuncture treatment + Basic treatment
control group:basic treatment

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged over 18 years old; (2) In line with the diagnosis of sensorineural hearing loss, that is, there are at least two frequencies at the 0.5khz, 1khz, 2khz, and 4khz levels where the binaural air conduction hearing threshold difference is greater than 20dB, and the air-bone conduction difference is less than 5db (3) Diagnosis consistent with MCI at the same time: (a) The patient or the insider reported, or the experienced clinician found cognitive impairment; (b) There was objective evidence of one or more cognitive impairment (from cognitive impairment test); (c) Complex instrumental daily abilities can be slightly impaired, but maintain independent daily living abilities; (d) The diagnosis of dementia has not yet been reached; (4) Patients should be included under the condition of signing the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with new cardiovascular and cerebrovascular diseases and hearing loss again in the past three months; (2) People with a history of large-scale cerebral infarction, patients with severe endocrine system diseases, patients with severe infectious diseases, and patients with toxic encephalopathy; (3) The patient has fainted needles, and the treatment site has skin breakage, infection and other contraindications that are not suitable for acupuncture treatment; (4) The patient is conscious or mentally disabled and cannot cooperate to complete the study; (5) Women with acute abdomen, pregnancy and lactation; (6) There is a history of head and neck trauma, and a history of taking special drugs; (7) In the past three months, the patient has accepted or is participating in other clinical trials; (8) Patients have contraindications to MRI scans, such as claustrophobia, tattoos, or implantation of ferromagnetic metals.

Design outcomes

Primary

MeasureTime frame
HADS;AFT;AVLT;fMRI;ADL;TMT;SRT;PTA;????????;PSQI;CDT;MoCA;ECog?????;

Countries

China

Contacts

Public ContactHui Xie
wangxie-ctu@163.com18908172382

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026